Key result
Hybrid coronary revascularisation shows limited perioperative benefit over conventional and off-pump CABG.
Why the study?
Limited evidence exists on whether hybrid coronary revascularisation reduces perioperative morbidity and mortality compared to conventional and off-pump CABG in stable multivessel coronary artery disease.
In patients with stable multivessel coronary artery disease, does the use of hybrid coronary revascularisation compared to conventional and off-pump coronary artery bypass grafting (CABG) reduce perioperative morbidity and mortality?
Systematic Review
In patients with stable multivessel coronary artery disease, does the use of hybrid coronary revascularisation compared to conventional and off-pump coronary artery bypass grafting (CABG) reduce perioperative morbidity and mortality?
Hybrid coronary revascularisation may offer perioperative benefits such as shorter hospital stays and fewer transfusions compared to CABG, but large randomized trials with longer follow-up are needed to establish clinical effectiveness.
No takes yet. Share an insight, caveat, or question.
Limited perioperative benefits with hybrid revascularisation should not yet change practice; leaves open need for randomized confirmation in multivessel disease.
Jones et al. (2010) conducted a systematic review in stable multivessel coronary artery disease. Hybrid coronary revascularisation vs. Conventional and off-pump coronary artery bypass grafting (CABG) was evaluated on Perioperative morbidity and mortality. Hybrid coronary revascularisation provided limited evidence of improved perioperative outcomes (shorter hospital stays, fewer transfusions) compared to conventional and off-pump CABG.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: